27. Zhu J, Chen H, Song Z, et al. Effects of ginger (Zingiber officinale Roscoe) on type 2 diabetes mellitus and components of the metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
28. Fernando WMADB, Somaratne G, Goozee KG, et al. Diabetes and Alzheimer’s disease: Can tea phytochemicals play a role in prevention?
29. Fu Q-Y, Li Q-S, Lin X-M, et al. Antidiabetic effects of tea.
30. Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies.
31. Öztürk E, Arslan AKK, Yerer MB, Bishayee A. Resveratrol and diabetes: A critical review of clinical studies.
32. Behloul N, Wu G. Genistein: A promising therapeutic agent for obesity and diabetes treatment.
33. Chen S, Jiang H, Wu X, Fang J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes.
34. Link LB, Potter JD. Raw versus cooked vegetables and cancer risk.
35. Roohbakhsh A, Karimi G, Iranshahi M. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review.
36. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: Causes and therapeutic strategies.
37. Yoo JY, Kim SS. Probiotics and prebiotics: present status and future perspectives on metabolic disorders.
38. Barengolts E. Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: Review of randomized controlled trials.
39. Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, et al. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials.
40. Baker EJ, Miles EA, Burdge GC, et al. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans.
41. Molfino A, Amabile MI, Monti M, Muscaritoli M. Omega-3 Polyunsaturated fatty acids in critical illness: Anti-inflammatory, proresolving, or both?
42. Bhaswant M, Poudyal H, Brown L. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids.
43. Trautwein EA, Koppenol WP, De Jong A, et al. Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes: A randomized, double-blind, placebo-controlled study.
44. Vilahur G, Ben-Aicha S, Diaz E, et al. Phytosterols and inflammation.
45. Derdemezis CS, Filippatos TD, Mikhailidis DP, Elisaf MS. Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering.
46. Cooper AJM, Sharp SJ, Luben RN, et al. The association between a biomarker score for fruit and vegetable intake and incident type 2 diabetes: the EPIC-Norfolk study.
47. Liang J, Zhang Y, Xue A, et al. Association between fruit, vegetable, seafood, and dairy intake and a reduction in the prevalence of type 2 diabetes in Qingdao, China.
48. Li M, Fan Y, Zhang X, et al. Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies.
49. Schwingshackl L, Hoffmann G, Lampousi A-M, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
50. Clark JL, Taylor CG, Zahradka P. Rebelling against the (insulin) resistance: A review of the proposed insulin-sensitizing actions of soybeans, chickpeas, and their bioactive compounds.
51. Agrawal S, Ebrahim S. Association between legume intake and self-reported diabetes among adult men and women in India.